In February 2015, the CDC (Centers for Disease Control & Prevention) published a new study which redefines the high impact of Clostridium difficile infections on the American health system. Published in the New England Journal of Medicine, the study reports nearly 500,000 infections among patients in the United States in 2011 caused by Clostridium difficile.
The study which identified nearly 500,000 cases of Clostridium difficile infection was conducted in 10 geographic areas of the United States. Approximately 29,000 patients died within 30 days of the initial diagnosis and, of those, about 15,000 deaths were estimated to be directly attributable to the Clostridium difficile infection. Moreover, More than 80 percent of the deaths associated with Clostridium difficile occurred among Americans aged 65 years or older. These results indicate that Clostridium difficile is a very important cause of infectious disease death in the United States.
Given the impact of Clostridium difficile on public health, the US CDC also announced that preventing Clostridium difficile infections is a National Priority in the USA. This paves the way for novel approaches like Da Volterra’s DAV132 to reduce the suffering and burden of Clostridium difficile for patients and health systems.
Click here to discover the press release of the CDC.
Click here to discover the article in the New England Journal Of Medicine.